Author

A. Ogunkanmi

Institution: Celgene (United States)

Observed institution: Celgene (United States)

OpenAlex ID: A5013471492

Robust: Phase Iii Randomized Study of Lenalidomide/r‐chop Vs Placebo/r‐chop in Untreated Abc‐type Diffuse Large B‐cell Lymphoma and Feasibility of Cell of Origin Subtyping

2017 · A. Chiappella, T.E. Witzig, et al. · Hematological Oncology

Works count: 1

Citation count:

H-index:

I10-index: